Weijie Ye
- Genetics top 5%
- Glioma Diagnosis and Treatment 4
- Cancer Research top 10%
- Immunology top 10%
- Immune cells in cancer 7
- Atherosclerosis and Cardiovascular Diseases 2
- Hepatology top 10%
- Pharmacology top 10%
-
- Ferroptosis and cancer prognosis 3
-
- Single-cell and spatial transcriptomics 2
- Glycosylation and Glycoproteins Research 1
-
- Pneumonia and Respiratory Infections 2
-
- Moyamoya disease diagnosis and treatment 1
- Cited by
- GeneticsCancer ResearchImmunology
- Journals
- Nature Communications (1 paper)ACS Applied Materials & Interfaces (1 paper)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Weijie Ye
16 papers receiving 941 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Genetics 231
- Cancer Research 191
- Immunology 257
- Hepatology 78
- Pharmacology 57
Countries citing papers authored by Weijie Ye
This map shows the geographic impact of Weijie Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijie Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijie Ye more than expected).
Fields of papers citing papers by Weijie Ye
This network shows the impact of papers produced by Weijie Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijie Ye. The network helps show where Weijie Ye may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weijie Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 13 | |
| 4 | 2022 | 9 | |
| 5 | 2022 | 44 | |
| 6 | Glioma targeted therapy: insight into future of molecular approachesbreakdown → | 2022 | 458 |
| 7 | 2022 | 2 | |
| 8 | 2021 | 22 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 25 | |
| 11 | 2019 | 279 | |
| 12 | 2019 | 3 | |
| 13 | 2019 | 21 | |
| 14 | 2018 | 24 | |
| 15 | 2018 | 16 | |
| 16 | 2017 | 18 |
About Weijie Ye
Weijie Ye is a scholar working on Immunology, Genetics and Psychiatry and Mental health, having authored 16 papers that have together received 946 indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Glioma Diagnosis and Treatment (4 papers), Ferroptosis and cancer prognosis (3 papers), Single-cell and spatial transcriptomics (2 papers), Pneumonia and Respiratory Infections (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Moyamoya disease diagnosis and treatment (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Genetics (231 citations), Cancer Research (191 citations) and Immunology (257 citations). Weijie Ye has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Quan Cheng, Zeyu Wang, Hao Zhang, Zhixiong Liu, Ziyu Dai, Liyang Zhang, Nan Zhang, Wantao Wu, Xun Zhang and Keyang Yang. Their work appears in journals such as Nature Communications, ACS Applied Materials & Interfaces and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.